Symbol="RCKT"
AssetType="Common Stock"
Name="Rocket Pharmaceuticals Inc"
Description="Rocket Pharmaceuticals, Inc., is a cross-platform biotechnology company focused on developing gene therapies for rare and devastating pediatric diseases. The company is headquartered in Cranbury, New Jersey."
CIK="1281895"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1233472000"
EBITDA="-253559008"
PERatio="None"
PEGRatio="None"
BookValue="5.0"
DividendPerShare="0"
DividendYield="0"
EPS="-3.13"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.361"
ReturnOnEquityTTM="-0.629"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-3.13"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="52.6"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="4.072"
EVToRevenue="-"
EVToEBITDA="-6.39"
Beta="1.153"
num_52WeekHigh="24.53"
num_52WeekLow="11.78"
num_50DayMovingAverage="19.33"
num_200DayMovingAverage="19.39"
SharesOutstanding="80461000"
DividendDate="2018-01-05"
ExDividendDate="None"
symbol="RCKT"
open="15.79"
high="15.85"
low="15.30"
price="15.33"
volume="406055.00"
latest_trading_day="2023-08-17"
previous_close="15.78"
change="-0.45"
change_percent="-2.8517%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="45"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="55"
Volume_recent_avg="683350"
Change_recent_avg="-0.03"
Delta_recent_avg="0.88"
Variance_recent_avg="0.44"
Change_ratio_recent_avg="-0.22"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="55"
Aroon_momentum_negative="45"
image_negative_thumbnail_id_1="163"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0013.jpeg"
image_negative_thumbnail_id_2="116"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0060.jpeg"
image_neutral_thumbnail_id_1="524"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0075.jpeg"
image_neutral_thumbnail_id_2="573"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0026.jpeg"
image_positive_thumbnail_id_1="981"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0143.jpeg"
image_positive_thumbnail_id_2="977"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0139.jpeg"
image_professor_thumbnail_id_1="1184"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
image_professor_thumbnail_id_2="1188"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
